tiprankstipranks
Advertisement
Advertisement
Grifols to evaluate potential IPO of U.S. Biopharma business
PremiumThe FlyGrifols to evaluate potential IPO of U.S. Biopharma business
1M ago
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
Premium
The Fly
Grifols price target lowered to EUR 11 from EUR 12 at Deutsche Bank
1M ago
Grifols shares results of Chronos Platforms identifying early Parkinson’s
Premium
The Fly
Grifols shares results of Chronos Platforms identifying early Parkinson’s
1M ago
Grifols sees 2026 adjusted EBITDA growth 5%-9%
PremiumThe FlyGrifols sees 2026 adjusted EBITDA growth 5%-9%
2M ago
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
GRFS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
Premium
Company Announcements
Grifols Adjusts Board Secretariat Roles Effective January 1, 2026
4M ago
Grifols SA Reports Strong Q3 Earnings Amid Challenges
PremiumCompany AnnouncementsGrifols SA Reports Strong Q3 Earnings Amid Challenges
6M ago
Grifols SA Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Grifols SA Reports Strong Q3 2025 Financial Results
6M ago
Grifols Reports Strong Q3 2025 Financial Performance with Biopharma Growth
Premium
Company Announcements
Grifols Reports Strong Q3 2025 Financial Performance with Biopharma Growth
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100